PubRank

Eric Dannaoui

Author PubWeight™ 33.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acquired resistance to echinocandins in Candida albicans: case report and review. J Antimicrob Chemother 2007 2.74
2 Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing. Antimicrob Agents Chemother 2008 2.54
3 Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis 2009 2.33
4 Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 2006 1.96
5 Healthcare-associated mucormycosis. Clin Infect Dis 2012 1.42
6 Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa. J Clin Microbiol 2009 1.36
7 Geosmithia argillacea: an emerging pathogen in patients with cystic fibrosis. J Clin Microbiol 2010 1.33
8 Detection of caspofungin resistance in Candida spp. by Etest. J Clin Microbiol 2008 1.29
9 Molecular identification of black-grain mycetoma agents. J Clin Microbiol 2006 1.28
10 Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother 2006 1.13
11 Antifungal susceptibility and phylogeny of opportunistic members of the order mucorales. J Clin Microbiol 2011 1.05
12 Combination of amphotericin B with flucytosine is active in vitro against flucytosine-resistant isolates of Cryptococcus neoformans. Antimicrob Agents Chemother 2006 1.03
13 In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates. Antimicrob Agents Chemother 2003 1.01
14 In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans. Antimicrob Agents Chemother 2002 0.99
15 Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis. Antimicrob Agents Chemother 2008 0.98
16 Antifungal combinations. Methods Mol Med 2005 0.97
17 Successful treatment of black-grain mycetoma with voriconazole. Am J Trop Med Hyg 2006 0.96
18 Carbon assimilation profiles as a tool for identification of zygomycetes. J Clin Microbiol 2007 0.92
19 Lack of evidence of endosymbiotic toxin-producing bacteria in clinical Rhizopus isolates. Mycoses 2008 0.88
20 Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol 2008 0.87
21 In vitro susceptibility to posaconazole of 1,903 yeast isolates recovered in France from 2003 to 2006 and tested by the method of the European committee on antimicrobial susceptibility testing. Antimicrob Agents Chemother 2007 0.84
22 Successful triple combination therapy of disseminated absidia corymbifera infection in an adolescent with osteosarcoma. J Pediatr Hematol Oncol 2010 0.83
23 An increasing trend of cutaneous zygomycosis caused by Mycocladus corymbifer (formerly Absidia corymbifera): report of two cases and review of primary cutaneous Mycocladus infections. Med Mycol 2009 0.82
24 Saksenaea vasiformis infection, French Guiana. Emerg Infect Dis 2008 0.81
25 Mutations in the Cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus isolated from avian farms in France and China. Poult Sci 2014 0.78
26 Pneumocystosis: survey and DHPS genotype analysis in 14 Parisian hospitals in 2003 and 2004. J Eukaryot Microbiol 2006 0.77
27 In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp. Antimicrob Agents Chemother 2012 0.76
28 Invasive infections due to Apophysomyces elegans. Mayo Clin Proc 2003 0.75
29 Molecular identification of fungi found on decomposed human bodies in forensic autopsy cases. Int J Legal Med 2014 0.75